The Study
A Multicenter Pilot Randomized Controlled Trial of a Digital Symptom Management Platform (WECARE) for Gastric Cancer Survivors
This study tried out a new app to help people feel better after stomach cancer surgery, but it didn't clearly make them feel better overall. It did show that lots of people liked using the app and stuck with it, which is good—but that doesn't mean the app fixed their symptoms.
Analysis score
Maximum 90 for a randomized controlled trial.
Where the score came from
After stomach cancer surgery, patients often feel unwell and need help managing symptoms at home. This study tested a phone app that asked patients daily about their symptoms and gave them personalized tips on food, exercise, and coping.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 575 / 100
Quality score
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Even though the app didn’t boost overall quality of life scores, patients felt more confident managing their symptoms — which matters for daily life.
- 287% of patients used the app regularly, 82% were happy with it, and 77% felt more in control of their recovery.
- 3But their overall quality of life scores didn’t improve more than those getting regular care.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Cancers
Year
2026
Authors
G. Song, J. Min, Rock Bum Kim, Ki Bum Park, B. W. Eom, J. Yun, Hoon Hur, Jeong Ho Song, Hayemin Lee, Su Mi Kim, Eun Young Kim, H. Yang, Joongyub Lee, Sang-Ho Jeong
Related Content
Claims (6)
Gastric cancer survivors who use a digital symptom management platform report a 77% higher sense of control over their symptoms, but their measurable quality of life does not improve.
Gastric cancer survivors using a digital symptom management platform showed a small, non-significant improvement in quality of life over six months compared to those receiving standard care.
Gastric cancer survivors who use a digital platform to report symptoms show a slight improvement in managing reflux, but their overall quality of life does not change significantly.
A digital tool that helps gastric cancer survivors manage symptoms after surgery, using personalized feedback and validated questionnaires, was used by 86.7% of patients over six months, and 82% reported being satisfied with it.
Among gastric cancer survivors, using a digital symptom management platform for six months results in no meaningful change in quality of life compared to standard care, based on a standardized quality-of-life score.
Postoperative gastric cancer patients who follow a personalized digital exercise and nutrition program have better health outcomes than those who receive standard care.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.